INTRODUÇÃO: Onicomicose é a infecção fúngica das unhas e é considerada a onicopatia mais frequente em adultos. Representa até 50% das lesões ungueais, sendo necessária confirmação diagnóstica com exame complementar que demostre a presença do fungo na unha, sendo o exame micológico direto e a cultura para fungos os mais utilizados. A dermatoscopia é um exame não invasivo, rápido e de baixo custo cujos padrões para onicomicose relatados na literatura em estudos retrospectivos chegam a 100% de sensibilidade e especificidade. Deste modo realizamos um estudo prospectivo para comparar a dermatoscopia frente ao exame micológico. MÉTODOS: Estudo prospectivo, transversal avaliando 109 pacientes e 202 unhas com suspeita diagnóstica de onicomicose. Os padrões dermatoscópicos encontrados foram descritos através de fotografias digitais. A sensibilidade e especificidade dos padrões de onicomicose distal-lateral foram determinados de acordo com o resultado do exame micológico. RESULTADOS: Foram significativos (p < 0,05) para o diagnóstico de onicomicose distal lateral e tiveram sensibilidade/especificidade calculadas os padrões: borda recortada (80,2% / 65,3%), borda linear (12,6% / 42,9%), estrias irregulares (81,1% / 65,3%), estrias finas/regulares (9,9% / 59,2%); e as cores branco (93,7% / 18,4%), amarelo (63,1% / 71,4%) e laranja (10,8% / 100%). Após análise multivariada stepwise forward os padrões de estrias irregulares, borda linear e cor amarela mantiveram significância estatística (p < 0,05). DISCUSSÃO: Os achados deste trabalho prospectivo estão de acordo com a literatura mostrando que há correlação entre o exame micológico e a dermatoscopia. Todavia, não ratifica a sensibilidade e especificidade de 100% encontrada em estudo retrospectivo para os padrões de borda recortada e borda linear. Também não demonstrado na literatura, as cores amarela, branca e laranja foram também estatisticamente significativas para o diagnóstico. CONCLUSÃO: A dermatoscopia correlaciona bem com a história natural da infecção fúngica e com o exame micológico, sendo um exame promissor para o diagnóstico de onicomicose. Sugerimos que futuros estudos comparem a dermatoscopia com exames considerados padrão-ouro (ex: microscopia de fluorescência e PCR) para detectar exames falso negativos / BACKGROUND: Onychomycosis is defined as a fungal infection of the nail and is considered the most common onychopathy in adults. It represents up to 50% of nail diseases and demonstration of the fungal pathogen is necessary for diagnostic confirmation. Direct mycological examination and fungal culture are commonly used for this purpose. Dermoscopy is a noninvasive, fast and inexpensive exam, reaching 100% diagnostic sensitivity and specificity for onychomycosis in retrospective studies. Thus, we conducted a prospective study to compare dermoscopy with mycological examination. METHODS Prospective, cross-sectional study with 109 patients and 202 nails evaluated. Dermoscopic patterns were described using digital photography and their sensitivity and specificity for distal-lateral onychomycosis were determined. RESULTS: Statistically significant (p < 0.05) patterns and colors for the diagnosis of distal-lateral onychomycosis and respective sensitivity / specificity: jagged edge (80.2% / 65.3%), linear edge (12.6% / 42 , 9%), longitudinal irregular streaks (81.1% / 65.3%), longitudinal fine / regular streaks (9.9% / 59.2%); white color (93.7% / 18.4%), yellow color (63.1% / 71.4%) and orange color (10.8% / 100%). After a stepwise forward multivariate analysis irregular streaks, linear edge and yellow color remained statistically significant (p < 0.05). DISCUSSION: Findings of this prospective study are in agreement with the literature showing that there is correlation between mycological examination and dermoscopy. However, this study does not agree with 100% sensitivity and specificity found in retrospective studies for jagged edge and linear edge patterns. In addition, white, yellow and orange colors were also statistically significant for the diagnosis of onychomycosis. CONCLUSION: Dermoscopy correlates well with the natural history of fungal nail infection and mycological examination, and we consider it a promising method for the diagnosis of onychomycosis. We suggest that future studies compare dermoscopy with a gold standard exam (ex: fluorescence microscopy, PCR) to detect false negative cases

Orientador: Silmara Meneguin / Coorientador: Hélio Amante Miot / Resumo: Tratou-se de um estudo metodológico que utilizou análises quantitativa e qualitativa com o objetivo de construir e validar um questionário multidimensional para avaliar a qualidade de vida relacionada ao melasma (HRQ-Melasma). Considerando que existe apenas um instrumento específico disponível na literatura para avaliar a QV em melasma e que o mesmo não foi desenvolvido seguindo os passos clássicos da psicometria, esse trabalho tornou-se indispensável ao ser desenvolvido com base na percepção simbólica dos pacientes e especialistas da área. A amostra foi constituída por cinco especialistas titulados pela Sociedade Brasileira de Dermatologia e 154 portadores de melasma facial. O instrumento de coleta de dados foi composto por duas fases. A primeira, uma fase qualitativa, onde se realizou um grupo focal com os especialistas da área para a definição das dimensões e posteriormente um grupo focal com portadores de melasma facial, para a definição dos itens preliminares através da percepção simbólica dos mesmos frente às manchas. Na segunda fase, quantitativa, foi apresentado aos participantes o questionário teste (49 itens), MELASQoL-PB, DLQI-BRA, Escala Visual de Incômodo, escore MASI e dados sociodemográficos. Para a redução dos itens foi utilizado o modelo de Rasch pertencente a TRI, excluindo 30 itens que continham pouca informação. A análise da dimensionalidade foi realizada através do ajuste do modelo multidimensional, confirmando a multidimensionalidade do questionário. Par... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: This is a methodological study using qualitative and quantitative analyzes aimed to develop and validate a multidimensional questionnaire to evaluate the quality of life related to melasma (HRQ-Melasma). Considering that there is only one specific instrument available in the literature to assess the quality of life in patients with melasma and whose elaboration has not followed classic steps in psychometry, this study has become indispensable to be developed based on the symbolic perception of the patients and experts of the area. The sample consisted of five dermatologists titrated by the Brazilian Society of Dermatology and 154 patients with facial melasma. Data collection consisted of two phases: The first, qualitative phase, where they held a focus group with experts in the field to define the dimensions and then a focus group with people with facial melasma, to define the preliminary items through the symbolic perception of the same face of the spots. In the second phase, quantitative, was presented to the participants the questionnaire test (49 items), MELASQoL-PB, DLQI-BRA, visual scale of nuisance, MASI score and sociodemographic data. The reduction of the items we used the Rasch model belonging to TRI, excluding 30 items that contained little information. The analysis of dimensionality was performed by adjustment the multidimensional model, confirming the multi-dimensionality of the questionnaire. To analyze the reliability and stability over time, we used Cronbach's... (Complete abstract click electronic access below) / Mestre

Trichodysplasia spinulosa (TS) é uma doença proliferativa de pele observada em pacientes imunocomprometidos. Caracteriza-se pela formação de espinhas de queratina conhecidos como espículas, acantose epidérmica, dilatação do folículo piloso, queratose actínica, queda dos pelos, pápulas foliculares e, que normalmente, se manifestam na região facial do paciente e extremidades do corpo (constantemente confundida com danos por exposição prolongada ao sol). A TS resulta da infecção ativa com o poliomavírus TSassociado (TSPyV), onde observa-se alta carga viral, expressão de proteína do vírus e formação de partículas. Este estudo desenvolveu métodos moleculares de detecção e sequenciamento do genoma total e parcial de TSPyV e utilizou-se destes métodos para determinar padrões de excreção e viremia em indivíduos imunocompromentidos e imunocompetentes, bem como explorar possíveis vias de transmissão. Ainda, características genéticas e filogenéticas do TSPyV também foram determinadas. Apesar de observamos alta taxa de excreção urinaria em indivíduos imunocomprometidos (57,7%), o vírus não foi encontrado em amostras de água do meio ambiente. Ainda em termos de excreção urinária do TSPyV, apenas 1,4% dos indivíduos imunocompetentes apresentaram virúria (diferente do que se observa para os poliomavirus JCPyV e BKPyV), mas o vírus foi encontrado em leite materno, sugerindo assim a possibilidade de haver transmissão vertical do TSPyV. As análises filogenéticas revelaram a existência de 2 linhagens de vírus circulantes em nosso meio, com características distintas dos já descritos na literatura. As diferenças observadas foram suficientes para que os vírus sejam caracterizados como novos genótipos circulantes de TSPyV. / Trichodysplasia spinulosa (TS) is a proliferative skin disease seen in immunocompromised patients. It is characterized by the formation of keratin spines known as spicules, epidermal acanthosis, hair follicle dilatation, actinic keratosis, hair loss, follicular papules and, which usually manifest in the facial region and extremities of the body (constantly confounded with damage from prolonged exposure to the sun). TS results from active infection with TS-associated polyomavirus (TSPyV), where high viral load, virus protein expression and particle formation are observed. This study developed molecular methods for detection and sequencing the total and partial genome of TSPyV and, employing these methods, determined patterns of excretion and viremia in immunocompromised and immunocompetent individuals, as well as explored possible transmission pathways. Genetic and phylogenetic characteristics were also determined. Although we observed high rate of urinary shedding in immunocompromised individuals (57.7%), the virus was not found in environmental water samples. Also in terms of urinary excretion of TSPyV, only 1.4% of immunocompetent individuals presented viruria (different from what is observed for polyomaviruses JCPyV and BKPyV), but the virus was found in breast milk, thus suggesting the possibility of vertical transmission. Phylogenetic analyzes revealed the existence of 2 circulating virus strains in our country, with different characteristics from those already described in the literature. The differences seem to be sufficient to characterize the viruses as new genotypes of TSPyV.

Background/Purpose: Research suggests that youth proximity to tanning salons may promote use; however, little is known about tanning salon proximity to schools. We assessed the proximity of tanning salons to schools in urban versus rural/suburban communities across Worcester County, Massachusetts (population > 800K). To put findings in context, we compared school proximity to tanning salons to school proximity to McDonald's restaurants, a large franchise that also caters to young people. Materials & Methods: Accessibility was measured by ArcGIS 10.2 Network Analyzer (ESRI, Redlands, CA, USA) and the most current road network data layer from Massachusetts Department of Transportation (MassDOT). Results: A total of 145 schools were observed in the study area, of which about 39% of schools were within 1 mile from a tanning salon. Urban schools (53.41%) had a higher proportion within 1 mile of a tanning salon than rural/suburban schools (17.54%; P < .001). More schools (39.31%) were within 1 mile of a tanning salon than schools within 1 mile of a McDonald's (22.70%; P < .001). Conclusions: Schools may be particularly impactful for implementing skin cancer prevention programing.

Cutaneous malignant melanoma (CMM) is one of the most rapidly increasing cancers in the Swedish population. The aetiology of melanoma is a complex interplay between genetics, host characteristics and environmental factors. The host characteristic with the strongest association with CMM is a phenotype with high numbers of common naevi and with dysplastic naevi. The principal environmental factor is sun exposure. Melanoma risk assessment (paper I) In a multi-national study including 986 subjects from Sweden, Denmark, the UK, Germany and the Netherlands, the ability of primary care physicians and nurses to identify individuals at increased melanoma risk was assessed. The atypical mole syndrome (AMS) scoring system for melanoma risk was used. The AMS scoring system consists of a five point check list incorporating total body naevus counts, clinically dysplastic naevi and body distribution of naevi. After brief training, the overall agreement in diagnosis between the trained personnel and experienced dermatologists was 94.5% (kappa value 0.70, p&lt;0.05). The study showed that the scoring system successfully can be taught to personnel in primary care. The naevus phenotype in a population in northern Sweden (paper II) The naevus phenotype was investigated in a population living in the inland of northern Sweden with a low melanoma incidence. Two hundred and one participants from the community of Storuman were included. The median naevus count was15 common naevi/individual, and the prevalence of dysplastic naevi was 11%. The median naevus count and prevalence of dysplastic naevi were significantly lower than previously described in populations with higher melanoma incidence and higher ambient ultraviolet exposure in southern Sweden. This geographical variation in naevus phenotype might be explained by differences in levels of sun exposure and in genotype. Cutaneous malignant melanoma in children and adolescents (papers III–V) During the years 1973 to 2002, 250 cases of primary CMM in individuals aged 0-19 years were reported to the Swedish Cancer Registry. Histological material was available for review in 87% of the cases registered during the two first decades (1973–1992). The diagnostic accuracy in the reviewed material was 88%. The melanoma incidence doubled in teenagers between the first decade (1973–1982) and the second (1983–1992). During the third decade (1993–2002) the increasing trend was broken. A decrease in incidence was noted in boys during 1993–1997, and in girls during 1998–2002. In younger children the incidence remained extremely low, only 4 cases in children aged 0–9 years were reported during the studied 30-year period. The trunk was the most common melanoma site in boys, and legs and trunk were the most common sites in girls. Superficial spreading melanoma was the most frequent subtype, followed by nodular melanoma. During the two first decades (1973–1992), the median melanoma thickness decreased from 1.5 to 0.9 mm. The melanoma-specific 5-year survival rate was 93%. The most important prognostic factor was melanoma thickness. The prognosis for thin lesions was excellent, during a median follow up time of 12 years, no tumour less than 0.8 mm was lethal according to the Registry. The results indicate that CMM in teenagers has many features in common with adult onset melanoma. The tudy also underlines the importance of not neglecting lesions suspected for malignant change in children and adolescents, as early detection and removal is crucial for the prognosis also in this young age group. / The electronic version of the thesis is a corrected version of the printed version.

Skin turbidity limits light based medical applications while increasing the risk of epidermal thermal injury. Collagen fibers are responsible for the majority of light scattering within skin. Chemicals, known as clearing agents, reduce tissue light scattering with the potential to increase the efficacy of light based imaging and therapeutic applications. Three hypotheses have been suggested for the clearing mechanism: index of refraction matching between clearing agent and collagen, tissue dehydration, and agent induced collagen structure perturbation. This study investigates optical clearing in skin while presenting a comprehensive clearing mechanism. Clearing was found to be a complex process with thermodynamic and kinetic components. Concentration gradients drive clearing agents to diffuse into skin and remove water. The introduction of clearing agents into the tissue reduces light scatter. The speed of clearing was found to increase with molecular size and number of hydroxyl groups. The molecular modeling program CHARMM suggests collagen affinity plays a major role in clearing agents’ ability to interact with collagen and remove bound water. Collagen solubility is a measure of clearing agent affinity for collagen and was found as a predictor of agent clearing potential. Increasing agent molecular size led to a greater reduction of fibrillogenesis with corresponding high collagen solubility. Raman spectroscopy quantified clearing agent induced dehydration of dermal collagen. Clearing agent ability to dehydrate dermal collagen corresponded with collagen affinity and the ability to clear tissue optically. The most effective clearing agents were found to remove bound water with the greatest efficacy. Replacement of collagen triple helix bound water by clearing agents with an index of refraction similar to collagen optically homogenizes skin tissue leading to a reduction in light scattering. Through dehydration of collagen with concomitant diffusion of clearing agent into collagen, the skin is homogenized leading to a large reduction in tissue light scattering.

Keloids are a fibroproliferative disorder of unknown etiology developing in the skin after injury or spontaneously. The aim of this thesis is to gain deeper insight into the role of TGF-β and its signaling pathway proteins, SMADs, in the pathogenesis of keloids and describe the gene expression profile in different keloid sites in the search for potential target genes for future treatment. Further aim is to develop an instrument to describe the quality of life of patients with keloids. We find cultured keloid fibroblasts to express an increased level of TGF-β1 mRNA and a decreased level of TGF-β3 mRNA compared to control skin. Keloid derived fibroblasts exhibit significantly decreased mRNA levels of TGF-β receptor type II (TβRII) and the ratio of TβRI/TβRII mRNA expression is increased. This suggests that a certain expression pattern of TGF-β subtypes and receptors may be important in keloid pathogenesis. Analysis of keloid derived fibroblasts reveal decreased SMAD3 mRNA expression and decreased ratio of SMAD2/SMAD3 mRNA implicating a disturbed SMAD signaling. Keloid fibroblasts up-regulate SMAD4 protein after stimulation with TGF-β1 and display diminished levels of the inhibitory proteins SMAD6 and 7. This may contribute to unlimited and deregulated TGF-β signaling leading to increased extracellular matrix production (ECM). The gene expression pattern is described in fibroblasts from different keloid sites using microarrays covering the whole human genome. This study reveals 105 regulated genes (79 genes are up- and 26 down-regulated) resulting in a unique gene expression profile in different sites of keloids, where progression or regression of the keloid process took place. In cells from the central part of keloids with clinical signs of regression, an up-regulation of apoptosis inducing genes as ADAM12 and ECM degrading genes as MMP19 is found. These genes may contribute to regression of keloids and might be possible future target genes for treatment. Overexpression of apoptosis inhibitors as AVEN and down-regulation of angiogenesis inhibiting genes as PTX3 found at the active margin of keloids may be responsible for the invasive character of the keloid margin. We develop a disease specific questionnaire to measure the quality of life of patients with keloids. We find two scales, psychological and physical impairment, describing the dimensions of quality of life in patients with scars. These two scales are independent of each other and show a high test-retest reliability. Single items which clinically characterize the disease show correlations to these scales. The results of this study demonstrate for the first time a severe impairment of quality of life of patients suffering from keloids and hypertrophic scars. In conclusion the described alteration in TGF-β expression and its receptors, the disrupted SMAD signaling pathway and the unique gene expression patterns in different keloid sites provide new knowledge on ECM formation and degradation in keloids. Regulatory genes in ECM homeostasis may be future target genes for keloid prevention, regression and treatment. The disease specific quality of life instrument of patients with keloids and scars is a useful tool to estimate success in future therapeutic efforts over time.

A large number of people all over the world suffer from skin conditions. Dermatological problems comprise about 10 % of a general practitioner's caseload and probably more for pharmacists. The literature furthermore emphasises that skin diseases are becoming a significant problem in the developing world. There is a need to establish an effective method to achieve good health and quality of life for patients with dermatological problems. The general objective of this study was to investigate the usage patterns and cost of dermatological products in the private health care sector of South Africa by using a medicine claims database. The focus was specifically on dermatological products with a prevalence of more than 10 % in the database. A quantitative retrospective drug utilisation research design was used to evaluate the usage patterns and costs of dermatological products in three four-monthly intervals of 2001 and 2004. Data were analysed by using the Statistical Analysis System, 9.1 (SAS). The dermatological product groups for this study were antibacterial and antifungal drugs, corticosteroids and anti-acne products and were analysed according to the MIMS classification. Of all analysed prescriptions issued only 8.57 % (n = 126 447) during 2001 (N = 1 475 380) and 6.82 % (n = 177 122) during 2004 (N = 2 595 254) consisted of dermatological products. Of the total number of products prescribed, the dermatological products constituted 4.77 %I (n = 140 701) for 2001 (N = 2 95 1 326) and 3.77 % (n = 199 976) for 2004 (N = 5 305 882). The total cost of the dermatological products was 4.98 % (n = R18 913 889.92) of the total cost of all medicine products during 200 1 (N = R379 708 489). During 2004 (N = R66 1 223 146) the total cost of dermatological products was 4.09 % (n = R27 025 540.48) of the total cost of all medicine products in the database. The cost-prevalence index for 2001 and 2004 respectively showed that the dermatological products were relatively expensive with values of 1.03 and 1.09. The antibacterial and antifungal drugs, corticosteroids and anti-acne products represented 91.92 % (n = 129 336) and 87.97 % (n = 175 9 16) of all dermatological products during 2001 (N = 140 701) and 2004 (N = 199 976), respectively. These dermatological groups named above represented 91.57 % (n = R17 319 645.61) and 85.85 '% (n = R23 200 594.71), respectively, of the total cost of dermatological products during 200 1 (N = R18 9 13 889.92) and 2004 (N = R27 025 540.48). It was further found that the majority of dermatological products prescribed during the research periods was innovator products. The prevalence of innovator products for 2001 was 86.17 % (n = 12 1 249) with a total cost representing 94.16 % (n = R17 809 603.12). For 2004 the prevalence was 82.33 % (n = 164 640) with a total cost representing 91 .O1 '% (n = R24 594 923.72) of all the dermatological products prescribed. The number of innovator and generic products claimed during 2001 amounted to 86.17 % (n = 12 1 249) and 13.83 % (n = 19 452) respectively of the total number of products claimed (N = 140 701). During 2004 the number of innovator and generic products represented respectively 82.33 % (n = 164 640) and 17.67 O/o (n = 35 336) of the total number of products claimed (N = 199 976). The prevalence in the use of the dermatological products during 2004 increased with 55.25 % from January to April versus September to December. The cost-prevalence index indicated that the dermatological products were relatively expensive during January to August 2004. During September to December 2004 the cost-prevalence decreased and indicated that dermatological products became inexpensive. The average cost of dermatological products during the 2004 study period showed that the cost decreased. January to April (before implementation of the new single exit price structure) was compared to September to December (after implementation of the new single exit price structure). This comparison indicated that the average cost decreased by 22.88 %. It can be summarised that the average cost in the last study period decreased due to the changed price structure. The innovator products' prevalence was high and therefore more generics are needed in dermatology. If more generics are used the total cost of dermatological products might also decrease. The number of dermatological prescriptions increased towards 2004, but this may be because of more members or more medical aids claiming through this database. / Thesis (M.Pharm.)--North-West University, Potchefstroom Campus, 2006.

A large number of people all over the world suffer from skin conditions. Dermatological problems comprise about 10 % of a general practitioner's caseload and probably more for pharmacists. The literature furthermore emphasises that skin diseases are becoming a significant problem in the developing world. There is a need to establish an effective method to achieve good health and quality of life for patients with dermatological problems. The general objective of this study was to investigate the usage patterns and cost of dermatological products in the private health care sector of South Africa by using a medicine claims database. The focus was specifically on dermatological products with a prevalence of more than 10 % in the database. A quantitative retrospective drug utilisation research design was used to evaluate the usage patterns and costs of dermatological products in three four-monthly intervals of 2001 and 2004. Data were analysed by using the Statistical Analysis System, 9.1 (SAS). The dermatological product groups for this study were antibacterial and antifungal drugs, corticosteroids and anti-acne products and were analysed according to the MIMS classification. Of all analysed prescriptions issued only 8.57 % (n = 126 447) during 2001 (N = 1 475 380) and 6.82 % (n = 177 122) during 2004 (N = 2 595 254) consisted of dermatological products. Of the total number of products prescribed, the dermatological products constituted 4.77 %I (n = 140 701) for 2001 (N = 2 95 1 326) and 3.77 % (n = 199 976) for 2004 (N = 5 305 882). The total cost of the dermatological products was 4.98 % (n = R18 913 889.92) of the total cost of all medicine products during 200 1 (N = R379 708 489). During 2004 (N = R66 1 223 146) the total cost of dermatological products was 4.09 % (n = R27 025 540.48) of the total cost of all medicine products in the database. The cost-prevalence index for 2001 and 2004 respectively showed that the dermatological products were relatively expensive with values of 1.03 and 1.09. The antibacterial and antifungal drugs, corticosteroids and anti-acne products represented 91.92 % (n = 129 336) and 87.97 % (n = 175 9 16) of all dermatological products during 2001 (N = 140 701) and 2004 (N = 199 976), respectively. These dermatological groups named above represented 91.57 % (n = R17 319 645.61) and 85.85 '% (n = R23 200 594.71), respectively, of the total cost of dermatological products during 200 1 (N = R18 9 13 889.92) and 2004 (N = R27 025 540.48). It was further found that the majority of dermatological products prescribed during the research periods was innovator products. The prevalence of innovator products for 2001 was 86.17 % (n = 12 1 249) with a total cost representing 94.16 % (n = R17 809 603.12). For 2004 the prevalence was 82.33 % (n = 164 640) with a total cost representing 91 .O1 '% (n = R24 594 923.72) of all the dermatological products prescribed. The number of innovator and generic products claimed during 2001 amounted to 86.17 % (n = 12 1 249) and 13.83 % (n = 19 452) respectively of the total number of products claimed (N = 140 701). During 2004 the number of innovator and generic products represented respectively 82.33 % (n = 164 640) and 17.67 O/o (n = 35 336) of the total number of products claimed (N = 199 976). The prevalence in the use of the dermatological products during 2004 increased with 55.25 % from January to April versus September to December. The cost-prevalence index indicated that the dermatological products were relatively expensive during January to August 2004. During September to December 2004 the cost-prevalence decreased and indicated that dermatological products became inexpensive. The average cost of dermatological products during the 2004 study period showed that the cost decreased. January to April (before implementation of the new single exit price structure) was compared to September to December (after implementation of the new single exit price structure). This comparison indicated that the average cost decreased by 22.88 %. It can be summarised that the average cost in the last study period decreased due to the changed price structure. The innovator products' prevalence was high and therefore more generics are needed in dermatology. If more generics are used the total cost of dermatological products might also decrease. The number of dermatological prescriptions increased towards 2004, but this may be because of more members or more medical aids claiming through this database. / Thesis (M.Pharm.)--North-West University, Potchefstroom Campus, 2006.

Thesis (doctoral)--Universite Paris 6--Pierre et Marie Curie, 1998. / Title from Summary page ; description based on resource as of 2005-06-17. "Année 1998." Includes bibliographical references.